Singapore markets close in 7 hours 40 minutes

Navamedic ASA (0FDB.L)

LSE - LSE Delayed Price. Currency in NOK
Add to watchlist
37.20+37.20 (-)
At close: 05:12PM GMT
Full screen
Previous close0.00
Open0.00
BidN/A x N/A
AskN/A x N/A
Day's range0.00 - 0.00
52-week range
Volume4,617
Avg. volume134
Market capN/A
Beta (5Y monthly)0.32
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives

    Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announced its results for the fourth quarter and for the full year 2023. Revenues for the year was up 34 per cent to NOK 512 million, mainly by organic growth. For the first time all three product categories were above the NOK 100 million mark.

  • PR Newswire

    Navamedic ASA: Invitation to 2023 4th quarter presentation

    Navamedic ASA (OSE: Nava) will be presenting its fourth quarter 2023 results on Thursday, February 15, 2024. The presentation will be held at Dronning Eufemias gate 16 in Oslo and the event will start at 08.30 CET. A link to the webcast and the presentation will be available through the Navamedic web site on the following link: https://navamedic.com/investors/financial-results/

  • PR Newswire

    Navamedic ASA: Renewed contract signed with Vitaflo International Limited

    Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces it has renewed its contract with Vitaflo International Limited (Vitaflo International), granting Navamedic the exclusive rights to market and distribute Vitaflo International's medical nutrition products across the Nordic region for an additional five years.